Dihydropyridine calcium channel blocker drugs - nifedipine
Last updated on September 26, 2024
| Generic name |
nifedipine |
|
|---|---|---|
|
Strength |
20 mg, 30 mg, 60 mg | |
|
Form |
extended release tablet |
|
|
Criteria |
Approval period |
|---|---|
|
1. Treatment failure on optimal dose of, or intolerance to, amlodipine. OR 2. Complex patient requiring medications for co-existing chronic condition(s). |
Indefinite |
Practitioner exemptions
Practitioners in the following specialty are not required to submit a Special Authority request form for coverage:
- Cardiologists
- Cardiovascular and Thoracic Surgery
- Internists specializing in cardiology
- Nephrologists
- Paediatrics
- Paediatric Cardiology
Special notes
- Immediate-release nifedipine capsules will be covered by Special Authority only for a person with a diagnosis of vasospastic angina (Prinzmetal angina).
- Patients with co-existing chronic conditions requiring use of multiple medications will be considered complex for the purposes of Special Authority criteria.
Special Authority request form(s)
- Log in to eForms
- 5328—General Special Authority Request